178 related articles for article (PubMed ID: 2922053)
1. A new strategy for the generation of catalytic antibodies.
Shokat KM; Leumann CJ; Sugasawara R; Schultz PG
Nature; 1989 Mar; 338(6212):269-71. PubMed ID: 2922053
[TBL] [Abstract][Full Text] [Related]
2. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
Thorn SN; Daniels RG; Auditor MT; Hilvert D
Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
[TBL] [Abstract][Full Text] [Related]
3. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
[TBL] [Abstract][Full Text] [Related]
4. New strategies for the design of catalytic antibodies.
Janda KD
Biotechnol Prog; 1990; 6(3):178-81. PubMed ID: 1366610
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for antibody catalysis of a disfavored ring closure reaction.
Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
[TBL] [Abstract][Full Text] [Related]
6. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
Tantillo DJ; Houk KN
J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
[TBL] [Abstract][Full Text] [Related]
7. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
Wulff G; Liu J
Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
Ulrich HD; Schultz PG
J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in catalytic antibodies.
Scanlon TS; Schultz PG
Philos Trans R Soc Lond B Biol Sci; 1991 May; 332(1263):157-64. PubMed ID: 1678534
[TBL] [Abstract][Full Text] [Related]
11. Immunological optimization of a generic hydrophobic pocket for high affinity hapten binding and Diels-Alder activity.
Piatesi A; Hilvert D
Chembiochem; 2004 Apr; 5(4):460-6. PubMed ID: 15185369
[TBL] [Abstract][Full Text] [Related]
12. Antibody catalysis of carbon-carbon bond formation.
Hilvert D
Ciba Found Symp; 1991; 159():174-83; discussion 183-7. PubMed ID: 1959446
[TBL] [Abstract][Full Text] [Related]
13. Genetic and fluorescence studies of affinity maturation in related antibodies.
Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
[TBL] [Abstract][Full Text] [Related]
14. Toward bifunctional antibody catalysis.
Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
[TBL] [Abstract][Full Text] [Related]
15. The generation of antibody combining sites containing catalytic residues.
Shokat KM; Schultz PG
Ciba Found Symp; 1991; 159():118-28; discussion 128-34. PubMed ID: 1959444
[TBL] [Abstract][Full Text] [Related]
16. Catalytic antibodies: hapten design strategies and screening methods.
Xu Y; Yamamoto N; Janda KD
Bioorg Med Chem; 2004 Oct; 12(20):5247-68. PubMed ID: 15388154
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
[TBL] [Abstract][Full Text] [Related]
18. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
Mouratou B; Stetefeld J
Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
[TBL] [Abstract][Full Text] [Related]
20. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
